Skip to main content
Premium Trial:

Request an Annual Quote

RainDance Technologies Forms French Subsidiary for Euro Partnering

NEW YORK (GenomeWeb News) – RainDance Technologies has formed a subsidiary in France that will focus on developing research partnerships in Europe, the company said today.
The new company, Raindance Technologies France SARL, will be based in Strasbourg at the Louis Pasteur University’s Institute of Science and Supramolecular Engineering. Andrew Griffiths, a RainDance founder, is director of the institute’s Chemical Biology Laboratory.
The subsidiary is expected to start operations at the beginning of September, RainDance said.
RainDance was founded in 2004 and is based in Lexington, Mass. It is developing an analytical platform that produces picoliter-volume droplets that can contain a single molecule, reaction, or cell, and are each the “functional equivalent of an individual test tube,” the company said.
The company plans to focus its initial application on human genome resequencing research.
The new subsidiary is expected to help RainDance develop collaborations with European groups studying genomics, molecular biology, and drug discovery, RainDance CEO, Chris McNary, said in a statement.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.